NEW YORK (GenomeWeb News) – Nanosphere said Friday that it will offer 15 million shares of its common stock in a public offering priced at $1.75 per share.

The Northbrook, Ill.-based molecular diagnostics company said that it expects to bring in net proceeds of around $24.1 million, or $27.7 million if the underwriters exercise their overallotment option of 2,250,000 shares in full. Funds from the offering will be used for general corporate purposes and working capital, Nanosphere said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.